Ipca Laboratories
Ipca Laboratories Ltd is an Indian pharmaceutical manufacturing company producing active pharmaceutical ingredients and finished dosage formulations. The company manufactures cardiovascular medicines, antimalarials, pain management drugs, anti-diabetics, and active pharmaceutical ingredients across global facilities. Main revenue drivers include domestic formulation sales in India alongside export sales of APIs and generic formulations to international regulated markets. Ipca Laboratories serves healthcare systems, prescription pharmacies, hospital networks, and pharmaceutical formulation companies across North America, Europe, Africa, and Asia. The company holds a market-leading position globally in antimalarial therapeutics and specific active pharmaceutical ingredient manufacturing. Headquartered in Mumbai, India, Ipca Laboratories Ltd is listed on the National Stock Exchange of India and the BSE.
2 of the funds FundTelligence covers report a position in Ipca Laboratories.
- Legal name
- Ipca Laboratories Ltd
- Sector
- Health Care
- Country
- India
- Funds holding it
- 2
Funds holding Ipca Laboratories
- BlackRock iShares MSCI EM IMI Screened UCITS ETF — BlackRock · 0.03 % (full portfolio disclosed, October 2026)
- Storebrand Indeks Nye Markeder — Storebrand · 0.01 % (full portfolio disclosed, October 2026)